This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Louis Labrousse Marc Laskar Permission Requests Google Scholar Articles by Pesteil, F. Articles by Laskar, M. PubMed PubMed Citation Articles by Pesteil, F. Articles by Laskar, M. Related Collections Great vessels

Preoperative hepatic insufficiency and type III endoleak: a confirmed potential fatal association following endovascular treatment

^a Department of Thoracic and Cardiovascular Surgery and Angiology, Dupuytren University Hospital, Ave Martin Luther King, 87042 Limoges, France
^b Department of Cardiac and Vascular Surgery, Hôpital Haut-Lévèque, Bordeaux University Hospital, 33604 Pessac, France

*Corresponding author. Department of Cardio-Vascular Surgery, Hôpital Haut Lévèque, Avenue de Magellan, 33604 Bordeaux-Pessac, France. Tel.: +33-5-57-65-64-37; fax: +33-5-57-65-81-57.

E-mail address: louis.labrousse{at}chu-bordeaux.fr (L. Labrousse).

Consumptive coagulopathy is known to occur in patients with aneurysm, especially in the thoracic localization. Compared to open chest surgery, the endovascular treatment leaves in place a large thrombosed aneurysmal sac, which might induce and/or exacerbate the coagulopathy. Although exceptional, some recent reports have raised the potential disastrous issue related to this complication. We report the case of a 74-year-old patient treated for an asymptomatic thoracic aorta aneurysm by endoprosthesis who developed a fatal disseminated intravascular coagulopathy. This complication has been related to a type III endoleak associated with a preoperative hepatic insufficiency.

Key Words: Thoracic aneurysm; Coagulopathy